Spectacular results for bluebird’s gene therapy in thalassemia
Tagrisso outperformed first-generation TKI drugs in FLAURA trial
Firms will co-develop Lenvima and Keytruda combinations
The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.
Swiss pharma builds on existing collaboration with Science 37